MITCHELL GOLD - 04 Jan 2023 Form 4 Insider Report for ALPINE IMMUNE SCIENCES, INC.

Role
Executive Chairman and CEO, Director
Signature
/s/ James Paul Rickey, attorney-in-fact
Issuer symbol
N/A
Transactions as of
04 Jan 2023
Net transactions value
$0
Form type
4
Filing time
05 Jan 2023, 18:04:54 UTC
Previous filing
06 Jan 2022
Next filing
12 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALPN Stock Option (Right to buy) Award $0 +350,000 $0.000000 350,000 04 Jan 2023 Common Stock 350,000 $7.55 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant.
F2 One-fourth (1/4th) of the Shares subject to the Option will vest on January 4, 2024, and one thirty-sixth (1/36th) of the remaining Shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to be a service provider through each such date.